Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
8,675,595
-
Share change
-
+1,726,263
-
Total reported value
-
$35,305,172
-
Put/Call ratio
-
98%
-
Price per share
-
$4.07
-
Number of holders
-
53
-
Value change
-
+$7,098,924
-
Number of buys
-
24
-
Number of sells
-
12
Institutional Holders of AMPIO PHARMACEUTICALS INC - COM (AMPE) as of Q4 2017
As of 31 Dec 2017,
AMPIO PHARMACEUTICALS INC - COM (AMPE) was held by
53 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,675,595 shares.
The largest 10 holders included
Knoll Capital Management, LP, Vanguard Group Inc, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, GROUP ONE TRADING, L.P., Carnick & Kubik Group, LLC, MILLENNIUM MANAGEMENT LLC, Noven Financial Group, Inc., NORTHERN TRUST CORP, and Cypress Capital Management LLC (WY).
This page lists
53
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.